Abstract
Secukinumab is an effective and safe treatment for refractory pityriasis rubra pilaris: a case report and literature review
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia
Paper Title
Journal
Date